16 completed, 4 terminated, 2 recruiting, 1 suspended. 23 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 23 | Completed 16, Terminated 4, Recruiting 2, Suspended 1 |
Follow Guerbet: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment Elucirem (Gadopiclenol) - Myocardial Fibrosis | Phase 4 | Recruiting | Johns Hopkins University | 25 | 2025-08-01 | 2026-04-13 |
| Gadopiclenol in Contrast Enhanced MRI of the Prostate Gadopiclenol - Prostate Cancer | Phase 4 | Suspended | Columbia University | 150 | 2024-02-14 | 2026-07-20 |
| Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years Motor Tests, Cognitive Tests, Unenhanced-MRI of the brain - Motor Function, Cognitive Function | Phase 4 | Recruiting | Guerbet | 2076 | 2021-03-24 | 2026-01-22 |
| Dotarem vs Gadobutrol Contrast for Breast MRI Gadoterate meglumine, Gadobutrol - Breast Diseases | Phase 4 | Completed | University of Massachusetts, Worcester | 300 | 2021-03-01 | 2026-03-17 |
| Sonographic Hysterosalpingography: Oil vs Water Based Media (SHOW Trial) Lipiodol UF, Saline - Infertility | Phase 4 | Completed | Milton S. Hershey Medical Center | 58 | 2019-01-11 | 2022-05-02 |
| A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures Lipiodol Ultra Fluid with surgical glues - Congenital Hemangioma, Hemangioendothelioma | Phase 4 | Completed | Guerbet | 132 | 2017-11-29 | 2025-10-10 |
| Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease Gadolinium - Meniere's Disease | Phase 4 | Terminated | University Hospital, Grenoble | 23 | 2016-03-16 | 2020-11-18 |
| DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years DOTAREM - Magnetic Resonance Imaging | Phase 4 | Completed | Guerbet | 51 | 2015-03-01 | 2017-03-09 |
| Evaluation of Gadoterate in Patients With Renal Dysfunction Gadoterate, No Gadoterate - Renal Dysfunction | Phase 4 | Terminated | Loyola University | 46 | 2014-11-05 | 2025-08-13 |
| Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors Dotarem®, Gadovist®/Gadavist® - Primary Brain Tumor | Phase 4 | Completed | Guerbet | 279 | 2014-06-01 | 2016-12-30 |
| DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC Gadoterate meglumine - Hepatocellular Carcinoma | Phase 4 | Terminated | Guerbet | 37 | 2013-05-09 | 2019-08-08 |
| Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography Iodixanol, Ioxaglate, Bivalirudin - Coronary Artery Disease | Phase 4 | Completed | NYU Langone Health | 100 | 2013-02-01 | 2016-04-06 |
| Hepatic Xenetix-CT Perfusion Xenetix-CT perfusion imaging - Hepatocellular Carcinoma | Phase 4 | Completed | Guerbet | 96 | 2012-04-01 | 2017-07-13 |
| Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography iobitridol, iopromide, iomeprol - Coronary Artery Disease | Phase 4 | Completed | Guerbet | 468 | 2010-11-01 | 2015-12-16 |
| Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis iobitridol, gadoterate meglumine - Type 2 Diabetes Mellitus, Coronary Atherosclerosis | Phase 4 | Completed | Guerbet | 351 | 2010-08-01 | 2019-05-31 |
| Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease Dotarem, Gadovist - Peripheral Arterial Disease | Phase 4 | Completed | Guerbet | 189 | 2009-10-01 | 2012-12-11 |
| DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in Patients With Abdominal or Lower Limb Arterial Diseases Contrast-enhanced MRA - Imaging examination - Peripheral Arterial Disease | Phase 4 | Completed | Guerbet | 20 | 2009-07-01 | 2012-11-02 |
| Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography Ioversol 320 mgI/mL, Iodixanol 320 mgI/mL - Renal Impairment | Phase 4 | Terminated | Guerbet | 6 | 2009-01-01 | 2019-03-06 |
| Renal Safety Evaluation After Dotarem®-Enhanced MRI Dotarem®-enhanced MRI, non-enhanced MRI - Renal Insufficiency | Phase 4 | Completed | Guerbet | 135 | 2008-01-01 | 2015-06-09 |
| A Clinical Study of Iobitridol in Patients Undergoing Multislice Computed Tomography (CT) Abdominal Angiography Iobitridol - Diagnostic Imaging | Phase 4 | Completed | Guerbet | 2006-08-01 | 2008-11-26 |
Showing 20 of 23. Sign in to see all of them.
Carcinoma, Hepatocellular (3) · Coronary Artery Disease (3) · Renal Insufficiency (3) · Peripheral Arterial Disease (2) · Prostatic Neoplasms (2) · Arterial Occlusive Diseases (1) · Arteriovenous Malformations (1) · Brain Neoplasms (1) · Breast Diseases (1) · Breast Neoplasms (1) · Colorectal Neoplasms (1) · Diabetes Mellitus, Type 2 (1) · Hemangioendothelioma (1) · Hemangiosarcoma (1) · Infertility (1)
gadoterate meglumine (9) · iobitridol (4) · gadobutrol (3) · iodixanol (3) · gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate (2) · gadopiclenol (2) · Gadolinium (1) · Ioxaglic Acid (1) · Neuropsychological Tests (1) · Sodium Chloride (1) · bivalirudin (1) · gadobenic acid (1) · gadodiamide (1) · gadolinium ethoxybenzyl DTPA (1) · gadoteridol (1)
United States (10) · France (8) · South Korea (6) · Austria (4) · Germany (3) · Italy (3) · Spain (2) · Switzerland (2) · Belgium (1) · Brazil (1) · Canada (1) · Colombia (1) · Hungary (1) · India (1) · Mexico (1)
Corinne Dubourdieu, PhD (3) · Eddie Darton, MD (2) · Ari Goldberg, MD (1) · Binita Shah, MD, MS (1) · Fred Feit, MD (1) · Gilbert Deray, Pr, MD, PhD (1) · Hatem Alkadhi (1) · Jeong Min Lee, Ph.D (1) · Jing Hao, MD (1) · Joao Lima, Professor (1) · Kenneth Maravilla, MD (1) · Nicholas Bloch, MD (1)